Chemical Structure (Lucemyra 01)
Lucemyra Tablet, Film Coated
Product Images NDC 78670-050
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lucemyra (NDC 78670-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Uswm, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lucemyra 02)
The text suggests a table featuring three treatment options- Lofexidine 2.16mg, Lofexidine 2.88mg, and Placebo. There is no available information apart from this, suggesting that the purpose of this text is to present a chart with study day and the proportion of subjects who have completed the treatment, with the figures masked here.*
Figure 2 (Lucemyra 03)
Figure 3 (Lucemyra 04)
Figure 4 (Lucemyra 05)
Principal Display Panel (0.18 mg Tablet Bottle Carton)
Lucemyrar is a medication available in tablet form (Fxonly NDC78670.050.96). The purpose of the medication is not stated, but the dosage and frequency information is not available. It is advised to be stored between 15°C and 86°F, away from heat and moisture. The medication should be dispensed by USWM, LLC, in the original packaging, and kept out of reach of children. The label includes a specific lot number (ABCDEF1234) and a serial number (SN 123456789012). The GTIN (Global Trade Item Number) is also included.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
